Suvretta Capital Management: 13F holdings, Q2 2026
Emerging, concentrated · SEC EDGAR filings (CIK 0001569064) · Explore on the interactive board
Suvretta Capital Management disclosed 95 US equity positions worth $4.8bn in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is MANE at 10.8% of the reported book, followed by ARQT, LEGN. The top ten holdings are 44.6% of the book, and the portfolio behaves like about 29 equal-weight positions. Versus the prior filing it opened 21 new positions, added to 25, reduced 17 and exited 14.
What does Suvretta Capital Management own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 21 new, 25 added, 17 reduced, 14 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | MANE VERADERMICS INC | 10.8% | $512.5m | 4,168,970 | 0% | held | |
| 2 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 6.9% | $326.1m | 12,437,000 | 1% | added |
| 3 | LEGN LEGEND BIOTECH CORP | Healthcare | 4.3% | $204.2m | 7,070,000 | -7% | reduced |
| 4 | PALVELLA THERAPEUTICS INC NE | 3.6% | $173.5m | 1,135,406 | -2% | reduced | |
| 5 | AVBP ARRIVENT BIOPHARMA INC | 3.3% | $156.9m | 4,515,531 | 3% | added | |
| 6 | BENITEC BIOPHARMA INC | 3.2% | $154.5m | 11,548,351 | 0% | held | |
| 7 | BHVN BIOHAVEN LTD | Healthcare | 3.2% | $153.1m | 10,286,937 | 0% | held |
| 8 | AMD ADVANCED MICRO DEVICES INC | Technology | 3.1% | $149.4m | 257,240 | 0% | held |
| 9 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 3.1% | $147.3m | 4,776,423 | -5% | reduced |
| 10 | TSM TAIWAN SEMICONDUCTOR MANUFAC | Technology | 3.1% | $145.5m | 304,627 | 2% | added |
| 11 | NVDA NVIDIA CORPORATION | Technology | 3.0% | $144.2m | 720,609 | 25% | added |
| 12 | EYPT EYEPOINT INC | Healthcare | 2.5% | $118.6m | 8,296,375 | 0% | held |
| 13 | SYY SYSCO CORP | Consumer Defensive | 2.5% | $118.0m | 1,411,550 | 22% | added |
| 14 | GE GE AEROSPACE | Industrials | 2.4% | $116.0m | 310,262 | 0% | held |
| 15 | IMTX IMMATICS N.V | Healthcare | 2.4% | $113.4m | 11,190,129 | 0% | held |
| 16 | MGM MGM RESORTS INTERNATIONAL | Consumer Cyclical | 2.3% | $111.2m | 2,325,360 | 8% | added |
| 17 | META META PLATFORMS INC | Communication Services | 2.1% | $99.0m | 175,807 | 4% | added |
| 18 | CAPR CAPRICOR THERAPEUTICS INC | Healthcare | 2.1% | $98.6m | 4,092,784 | 7% | added |
| 19 | KURA KURA ONCOLOGY INC | Healthcare | 2.0% | $94.1m | 8,575,422 | 0% | held |
| 20 | GLUE MONTE ROSA THERAPEUTICS INC | 1.8% | $85.9m | 3,549,539 | -16% | reduced | |
| 21 | AVALYN PHARMACEUTICALS INC | 1.7% | $82.4m | 2,503,109 | – | new | |
| 22 | HD HOME DEPOT INC | Consumer Cyclical | 1.7% | $79.7m | 226,053 | 2% | added |
| 23 | HUT HUT 8 CORP | Financial Services | 1.6% | $77.3m | 670,000 | – | new |
| 24 | COF CAPITAL ONE FINL CORP | Financial Services | 1.4% | $66.8m | 333,098 | 10% | added |
| 25 | VMC VULCAN MATLS CO | Basic Materials | 1.3% | $63.4m | 214,978 | 18% | added |
| 26 | FERG FERGUSON ENTERPRISES INC | Industrials | 1.2% | $58.6m | 246,758 | 16% | added |
| 27 | ZURA ZURA BIO LTD | Healthcare | 1.2% | $55.7m | 9,443,001 | 4% | added |
| 28 | INFLARX NV | 1.1% | $51.4m | 22,933,910 | 189% | added | |
| 29 | AURA AURA BIOSCIENCES INC | 1.1% | $51.2m | 7,206,217 | 65% | added | |
| 30 | FTH FAETH THERAPEUTICS INC | 1.1% | $50.5m | 2,020,103 | 5747% | added | |
| 31 | ADVISORSHARES TR | 1.0% | $49.5m | 9,738,524 | 8% | added | |
| 32 | AMZN AMAZON COM INC | Consumer Cyclical | 1.0% | $48.8m | 204,860 | -19% | reduced |
| 33 | REPL REPLIMUNE GROUP INC | Healthcare | 1.0% | $48.6m | 4,389,836 | 4% | added |
| 34 | APH AMPHENOL CORP | Technology | 1.0% | $47.5m | 269,300 | – | new |
| 35 | SPOT SPOTIFY TECHNOLOGY S A | Communication Services | 1.0% | $46.7m | 101,800 | 9155% | added |
| 36 | CTNM CONTINEUM THERAPEUTICS INC | 1.0% | $46.6m | 2,841,334 | 0% | held | |
| 37 | APO APOLLO GLOBAL MGMT INC | Financial Services | 1.0% | $45.3m | 383,300 | -1% | reduced |
| 38 | BAC BANK OF AMER CORP | Financial Services | 0.9% | $45.0m | 789,720 | -39% | reduced |
| 39 | ROUNDHILL ETF TRUST | 0.9% | $44.5m | 603,000 | – | new | |
| 40 | CRINETICS PHARMACEUTICALS IN | 0.9% | $44.4m | 1,186,279 | 14% | added | |
| 41 | CBRS CEREBRAS SYSTEMS INC | 0.8% | $38.0m | 171,900 | – | new | |
| 42 | DKS DICKS SPORTING GOODS INC | Consumer Cyclical | 0.7% | $34.3m | 151,320 | – | new |
| 43 | AVGO BROADCOM INC | Technology | 0.7% | $31.6m | 83,600 | – | new |
| 44 | CMPX COMPASS THERAPEUTICS INC | 0.6% | $30.9m | 14,101,159 | -1% | reduced | |
| 45 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.6% | $29.7m | 6,384,200 | 411% | added |
| 46 | UNH UNITEDHEALTH GROUP INC | Healthcare | 0.6% | $26.7m | 64,130 | -36% | reduced |
| 47 | PROK PROKIDNEY CORP | 0.5% | $25.2m | 12,341,266 | 0% | held | |
| 48 | WHWK WHITEHAWK THERAPEUTICS INC | Healthcare | 0.4% | $19.7m | 4,300,000 | 16% | added |
| 49 | SPACE EXPLORATION TECHN CORP | 0.4% | $17.3m | 101,200 | – | new | |
| 50 | MLM MARTIN MARIETTA MATLS INC | Basic Materials | 0.3% | $15.0m | 26,000 | – | new |
What did Suvretta Capital Management sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| APELLIS PHARMACEUTICALS INC | 41.3% | $141.5m |
| 4XC1 KALVISTA PHARMACEUTICALS INC | 28.0% | $96.0m |
| ERAS ERASCA INC | 16.2% | $55.6m |
| LTH LIFE TIME GROUP HOLDINGS INC | 4.0% | $13.7m |
| WING WINGSTOP INC | 2.7% | $9.2m |
| COHR COHERENT CORP | 2.1% | $7.1m |
| MDT MEDTRONIC PLC | 1.8% | $6.3m |
| KEZAR LIFE SCIENCES INC | 1.6% | $5.3m |
| MTD METTLER TOLEDO INTERNATIONAL | 0.7% | $2.5m |
| TSLA TESLA INC | 0.6% | $1.9m |
| TLN TALEN ENERGY CORP | 0.6% | $1.9m |
| VST VISTRA CORP | 0.3% | $902.0k |
| RBLX ROBLOX CORP | 0.1% | $476.2k |
| VRDN VIRIDIAN THERAPEUTICS INC | 0.1% | $326.7k |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 32.2% |
| Technology | 11.0% |
| Consumer Cyclical | 6.0% |
| Financial Services | 4.9% |
| Industrials | 3.9% |
| Communication Services | 3.1% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
| Quarter | Positions | Equity value |
|---|---|---|
| Q2 2026 | 95 | $4.8bn |
| Q1 2026 | 88 | $3.7bn |
| Q4 2025 | 90 | $4.0bn |
| Q3 2025 | 90 | $3.3bn |
| Q2 2025 | 95 | $2.7bn |
| Q1 2025 | 99 | $2.5bn |
| Q4 2024 | 94 | $2.7bn |
| Q3 2024 | 96 | $2.8bn |
| Q2 2024 | 97 | $2.5bn |
| Q1 2024 | 99 | $2.4bn |
| Q4 2023 | 87 | $2.2bn |
| Q3 2023 | 87 | $1.9bn |
| Q2 2023 | 100 | $1.9bn |
| Q1 2023 | 92 | $2.1bn |
| Q4 2022 | 89 | $2.4bn |
| Q3 2022 | 72 | $2.4bn |
Earliest filing: Q4 2013 · 51 quarters on file
How concentrated is Suvretta Capital Management's portfolio?
Across every quarter Suvretta Capital Management has filed, its median largest position is 7.7% of the book and its median top-ten weight is 47.6%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 796 completed holding spells, the median lasted 2.0 quarters; 95 positions are still open and their final length is unknown.